These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3882376)

  • 1. The effect of in-line filtration on tobramycin delivery.
    Elenbaas JK; Lander RD; Elenbaas RM
    Drug Intell Clin Pharm; 1985 Feb; 19(2):122-5. PubMed ID: 3882376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin interferes with tobramycin serum concentration determinations by Emit.
    Matzke GR; Piveral K; Halstenson CE; Abraham PA
    Drug Intell Clin Pharm; 1984 Jun; 18(6):517-9. PubMed ID: 6376040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of IV medications via soluset.
    Ford NA; Drott HR; Cieplinski-Robertson JA
    Pediatr Nurs; 2003; 29(4):283-6, 319. PubMed ID: 12956548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Decrease in the concentration of tobramycin, vancomycin and phenobarbital in administration with infusion filter].
    Böhrer H; Zhang CH; Krier C
    Infusionstherapie; 1991 Apr; 18(2):96-100. PubMed ID: 1856006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified enzyme immunoassays for tobramycin using reduced sample and reagent volumes.
    Lewis AS; Taylor G; Rowe HN; Williams HO; Lewis MH
    Am J Hosp Pharm; 1987 Mar; 44(3):568-71. PubMed ID: 3551596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nebulizer configuration on delivery of aerosolized tobramycin.
    O'Riordan TG; Amram JC
    J Aerosol Med; 1997; 10(1):13-23. PubMed ID: 10166359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of tobramycin sulfate in admixtures with calcium gluconate.
    Nahata MC; Durrell DE
    Am J Hosp Pharm; 1985 Sep; 42(9):1987-8. PubMed ID: 3901742
    [No Abstract]   [Full Text] [Related]  

  • 8. Compatibility and stability of clindamycin phosphate-aminoglycoside combinations within polypropylene syringes.
    Zbrozek AS; Marble DA; Bosso JA; Bair JN; Townsend RJ
    Drug Intell Clin Pharm; 1987 Oct; 21(10):806-10. PubMed ID: 3428140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of tobramycin delivery by four i.v. infusion methods.
    Pleasants RA; Sawyer WT; Williams DM; McKenna WR; Brown JM; Powell JR
    Clin Pharm; 1988 May; 7(5):367-73. PubMed ID: 3383542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of tobramycin levels obtained from central venous access devices in patients with cystic fibrosis is technique dependent.
    Mogayzel PJ; Pierce E; Mills J; McNeil A; Loehr K; Joplin R; McMahan S; Carson KA
    Pediatr Nurs; 2008; 34(6):464-8; quiz 468-9. PubMed ID: 19263753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.
    Lim AK; Mathanasenarajah G; Larmour I
    Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release infusion kinetics of tobramycin.
    Lane JR; Murray WE; Willenborg NL; Wilcox CL; Connor JD; Adler DS
    Ther Drug Monit; 1989; 11(3):264-8. PubMed ID: 2728084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiency of pulmonary administration of tobramycin solution for inhalation in cystic fibrosis using an improved drug delivery system.
    Geller DE; Rosenfeld M; Waltz DA; Wilmott RW;
    Chest; 2003 Jan; 123(1):28-36. PubMed ID: 12527599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of an immunoassay and a microbiological assay for tobramycin serum concentrations.
    Fukuchi H; Yoshida M; Okihara M; Tokuoka S; Konishi T
    Am J Hosp Pharm; 1981 Dec; 38(12):1933-6. PubMed ID: 6798863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility of clindamycin phosphate with amikacin sulfate at room temperature and with gentamicin sulfate and tobramycin sulfate under frozen conditions.
    Marble DA; Bosso JA; Townsend RJ
    Drug Intell Clin Pharm; 1986 Dec; 20(12):960-3. PubMed ID: 3816545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of inhaled tobramycin affects assessment of intravenous tobramycin pharmacokinetic monitoring.
    Stenbit AE; Bullington WM; Heh JL; Flume PA
    J Cyst Fibros; 2013 Jul; 12(4):403-6. PubMed ID: 23266092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of peak sputum tobramycin concentration in patients with cystic fibrosis using jet and ultrasonic nebulizer systems. Aerosolized Tobramycin Study Group.
    Eisenberg J; Pepe M; Williams-Warren J; Vasiliev M; Montgomery AB; Smith AL; Ramsey BW
    Chest; 1997 Apr; 111(4):955-62. PubMed ID: 9106575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of inline filtration on the potency of low-dose drugs.
    Butler DL; Munson JM; DeLuca PP
    Am J Hosp Pharm; 1980 Jul; 37(7):935-41. PubMed ID: 7395887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study evaluating tobramycin pharmacokinetics and optimal once daily dosing in burn patients.
    Lee C; Walker SAN; Walker SE; Seto W; Simor A; Jeschke M
    Burns; 2017 Dec; 43(8):1766-1774. PubMed ID: 28647460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gentamicin, tobramycin, amikacin, and netilmicin levels in tears following intravenous administration.
    Woo FL; Johnson AP; Insler MS; George WJ; LaCorte WS
    Arch Ophthalmol; 1985 Feb; 103(2):216-8. PubMed ID: 3977692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.